Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fasciitis, Plantar Achillodynia Epikondylopathia Humeri /Radii Fasciitis Foot Diseases Musculoskeletal Diseases Periarthritis Calcarea

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital

Zurich, Switzerland

About this study

Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Patients with:

Fascititis plantaris,
Achillodynie,
Periarthropathia humerosacpularis calcarea or
Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria

Anticoagulation,
Sepsis

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Important dates

Study start: 2011
Primary completion: 2015
Study completion: 2015
First posted: Sep 7, 2011
Registry last updated: Jun 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed